Aemetis, Inc (NASDAQ:AMTX)‘s stock had its “neutral” rating reissued by stock analysts at FBR & Co in a report released on Saturday. They presently have a $2.00 price target on the specialty chemicals company’s stock. FBR & Co’s price objective indicates a potential upside of 85.19% from the stock’s previous close.
Separately, Zacks Investment Research upgraded shares of Aemetis from a “sell” rating to a “hold” rating in a report on Thursday, July 20th.
Shares of Aemetis (NASDAQ AMTX) opened at 1.08 on Friday. The stock’s market capitalization is $21.41 million. The stock has a 50 day moving average price of $1.21 and a 200 day moving average price of $1.28. Aemetis has a 52 week low of $0.95 and a 52 week high of $2.50.
ILLEGAL ACTIVITY NOTICE: “Aemetis’ (AMTX) Neutral Rating Reaffirmed at FBR & Co” was originally reported by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this article on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://stocknewstimes.com/2017/08/19/aemetis-amtx-neutral-rating-reaffirmed-at-fbr-co.html.
An institutional investor recently raised its position in Aemetis stock. Geneva Advisors LLC raised its stake in shares of Aemetis, Inc (NASDAQ:AMTX) by 2.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,511,631 shares of the specialty chemicals company’s stock after buying an additional 32,400 shares during the period. Geneva Advisors LLC owned 7.67% of Aemetis worth $1,950,000 as of its most recent SEC filing. Institutional investors own 18.87% of the company’s stock.
Aemetis Company Profile
Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.
Receive News & Ratings for Aemetis Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis Inc and related companies with MarketBeat.com's FREE daily email newsletter.
